This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2001;285:1570-1571.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2001;50:162-166

2 tables, 1 figure omitted

Colorectal cancer is the second leading cause of cancer-related death in the United States.¹ An estimated 135,400 new cases and 56,700 deaths from colorectal cancer are expected during 2001.¹ Since the mid-1990s, national guidelines have recommended that persons aged 50 years at average risk for colorectal cancer should have screening tests regularly. To estimate rates for the use of colorectal cancer screening tests and to evaluate trends in test use, CDC analyzed data from the 1999 Behavioral Risk Factor Surveillance System (BRFSS) on the use of a home administered fecal occult blood test (FOBT) and sigmoidoscopy/colonoscopy, and then compared them with similar data from 1997. The findings in this report indicate that the proportion of the U.S. population that has been screened remains low. In 1999, 44% of BRFSS respondents reported receiving FOBT and/or sigmoidoscopy/colonoscopy within the recommended period compared with approximately 41% . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population
Kuehle et al.
Gut 2007;56:1079-1085.
ABSTRACT | FULL TEXT  

The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Dube et al.
ANN INTERN MED 2007;146:365-375.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Rostom et al.
ANN INTERN MED 2007;146:376-389.
ABSTRACT | FULL TEXT  

Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs
Kelloff et al.
Clin. Cancer Res. 2004;10:3908-3918.
FULL TEXT  

Colorectal Cancer Screening for Persons at Average Risk
Anderson et al.
JNCI J Natl Cancer Inst 2002;94:1126-1133.
FULL TEXT  

Detection of APC Mutations in Fecal DNA from Patients with Colorectal Tumors
Traverso et al.
NEJM 2002;346:311-320.
ABSTRACT | FULL TEXT  

Fecal occult blood testing for colorectal cancer: a perspective
Barry
Ann Oncol 2002;13:61-64.
ABSTRACT | FULL TEXT